QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 2 September 2020Portfolio NewsClarify Medical Now Approved as a MultiPlan Participating Provider
- 10 August 2020SV NewsSV Health Investors discuss the firm’s new $90M early-stage Medtech Convergence Fund
- 15 July 2020SV NewsSV Health Investors announces the appointment of Allan May and Ryan Pierce as venture partners to the Medtech Convergence Fund
- 13 July 2020SV NewsPaul LaViolette Appointed to Edwards Lifesciences Board of Directors
- 24 June 2020Portfolio NewsClarify Medical Appoints John E. Schellhorn as President and Chief Executive Officer
- 6 April 2020SV NewsSV Health Investors announces formation of the Medtech Convergence Fund
- 18 November 2019Portfolio NewsEBT Secures USD$10M Series A
- 23 October 2019Portfolio NewsClarify Medical Closes $18M Series A Round to Commercialize its Connected Home Phototherapy System in the US